rs10489627

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001374259.2(IL12RB2):​c.-44A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.418 in 152,084 control chromosomes in the GnomAD database, including 14,883 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 14883 hom., cov: 32)
Exomes 𝑓: 0.17 ( 0 hom. )

Consequence

IL12RB2
NM_001374259.2 5_prime_UTR

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.840

Publications

15 publications found
Variant links:
Genes affected
IL12RB2 (HGNC:5972): (interleukin 12 receptor subunit beta 2) The protein encoded by this gene is a type I transmembrane protein identified as a subunit of the interleukin 12 receptor complex. The coexpression of this and IL12RB1 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. The expression of this gene is up-regulated by interferon gamma in Th1 cells, and plays a role in Th1 cell differentiation. The up-regulation of this gene is found to be associated with a number of infectious diseases, such as Crohn's disease and leprosy, which is thought to contribute to the inflammatory response and host defense. Several transcript variants encoding different isoforms and non-protein coding transcripts have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001374259.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.631 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001374259.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12RB2
NM_001374259.2
MANE Select
c.-44A>G
5_prime_UTR
Exon 2 of 17NP_001361188.1Q99665-1
IL12RB2
NM_001258214.1
c.-44A>G
5_prime_UTR
Exon 2 of 16NP_001245143.1B4DGA4
IL12RB2
NM_001319233.1
c.-40A>G
5_prime_UTR
Exon 2 of 16NP_001306162.1B4DGA4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IL12RB2
ENST00000674203.2
MANE Select
c.-44A>G
5_prime_UTR
Exon 2 of 17ENSP00000501329.1Q99665-1
IL12RB2
ENST00000541374.6
TSL:1
c.-44A>G
5_prime_UTR
Exon 2 of 13ENSP00000445276.3A0A0A0MTN7
IL12RB2
ENST00000262345.5
TSL:1
c.-37+6026A>G
intron
N/AENSP00000262345.1Q99665-1

Frequencies

GnomAD3 genomes
AF:
0.418
AC:
63515
AN:
151960
Hom.:
14843
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.636
Gnomad AMI
AF:
0.303
Gnomad AMR
AF:
0.401
Gnomad ASJ
AF:
0.386
Gnomad EAS
AF:
0.239
Gnomad SAS
AF:
0.317
Gnomad FIN
AF:
0.244
Gnomad MID
AF:
0.465
Gnomad NFE
AF:
0.339
Gnomad OTH
AF:
0.438
GnomAD4 exome
AF:
0.167
AC:
1
AN:
6
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
4
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.500
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
4
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.825
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.418
AC:
63610
AN:
152078
Hom.:
14883
Cov.:
32
AF XY:
0.412
AC XY:
30626
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.637
AC:
26402
AN:
41442
American (AMR)
AF:
0.400
AC:
6116
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.386
AC:
1340
AN:
3470
East Asian (EAS)
AF:
0.239
AC:
1236
AN:
5180
South Asian (SAS)
AF:
0.316
AC:
1523
AN:
4814
European-Finnish (FIN)
AF:
0.244
AC:
2582
AN:
10590
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.339
AC:
23072
AN:
67978
Other (OTH)
AF:
0.440
AC:
929
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1760
3519
5279
7038
8798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.359
Hom.:
17086
Bravo
AF:
0.442
Asia WGS
AF:
0.357
AC:
1244
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
8.2
DANN
Benign
0.82
PhyloP100
-0.84
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10489627;
hg19: chr1-67779676;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.